Building Equity Through Experience: Insights From 1560 Single-Center Pediatric Liver Transplants in a Developing

João Seda Neto1,2,3, Paulo Chapchap1, Eduardo A Fonseca1,2,3

  • 1Hepatology and Liver Transplantation, Hospital Sírio-Libanês, São Paulo, Brazil.

Pediatric Transplantation
|November 6, 2025
PubMed

Insights

A São Paulo transplant team achieved excellent pediatric liver transplant (PLT) outcomes, performing 1560 procedures over 34 years. Despite success, challenges like underfunding and access disparities persist in low- and middle-income countries.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Pediatric Gastroenterology

Background:

  • A single transplant center in São Paulo, Brazil, has accumulated extensive experience in pediatric liver transplantation (PLT) over 34 years.
  • The center has performed 1560 PLTs, including living donor liver transplants (LDLT), deceased donor liver transplants (DDT), and domino procedures.
  • Recent outcomes in a cohort of 500 PLTs (2018-2024) demonstrate high 1- and 5-year patient survival rates of 96.7% and 94.8%.

Purpose of the Study:

  • To report the long-term outcomes and experience of a high-volume pediatric liver transplant program in a low- and middle-income country.
  • To highlight the center's significant contribution to PLT in Brazil, particularly for young children.
  • To identify and discuss key barriers to sustainable and equitable PLT development in Brazil and propose guiding principles.

Main Methods:

  • Retrospective analysis of pediatric liver transplant data from a single center over 34 years.
  • Detailed review of patient survival rates and procedure types, including LDLT, DDT, and domino procedures.
  • Analysis of the center's contribution to national PLT statistics and identification of systemic challenges.

Main Results:

  • Over 34 years, 1560 pediatric liver transplants were performed, with 1352 LDLT, 179 DDT, and 29 domino procedures.
  • In the most recent cohort (2018-2024), 1- and 5-year patient survival rates were 96.7% and 94.8%, respectively.
  • The center performed 35.1% of all PLTs in Brazil from 2015-2024, and 45.5% of those in children under 5, with 98.1% utilizing LDLT.

Conclusions:

  • Excellent long-term outcomes in pediatric liver transplantation are achievable even in resource-constrained settings.
  • Significant structural challenges, including underfunding and access disparities, hinder equitable PLT development in Brazil.
  • Institutional commitment, strategic investment, and national coordination are crucial for advancing pediatric liver transplantation and ensuring equitable access.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
315
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
883
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
846